What is Pediatapp?
Pediatapp is a decongestant. It works by constricting (shrinking) blood vessels (veins and arteries) in your body. Constriction of blood vessels in your sinuses, nose, and chest allows drainage of those areas, which decreases congestion.
Pediatapp is used to treat the congestion associated with allergies, hay fever, sinus irritation, and the common cold. Pediatapp also causes a decrease in appetite and is used in some over-the-counter diet aids.
Pediatapp has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain Pediatapp.
Pediatapp may also be used for purposes other than those listed in this medication guide.
Pediatapp indications
influenza symptoms, cough
Uses of Pediatapp in details
Pediatapp is used to relieve blocked nose or sinuses caused by common cold and seasonal nasal allergies (hay fever). It is also used to decrease appetite for weight Pediatapp.
Pediatapp description
Pediatapp has been withdrawn in Canada and the United States. In November 2000, the Food and Drug Administration (FDA) issued a public health advisory against the use of the drug.
Pediatapp dosage
Pediatapp Dosage
Applies to the following strengths: 75 mg; 25 mg; 37.5 mg; 50 mg; 180 mg-75 mg
Usual Adult Dose for:
- Nasal Congestion
- Weight Loss
Usual Pediatric Dose for:
- Nasal Congestion
Additional dosage information:
- Renal Dose Adjustments
- Other Comments
Usual Adult Dose for Nasal Congestion
25 mg orally every 4 hours.
-or-
75 mg orally extended release every 12 hours.
Not to exceed 150 mg/day.
Usual Adult Dose for Weight Loss
25 mg orally 3 times a day, one-half hour before meals.
-or-
75 mg orally extended release once a day in the morning.
The use of Pediatapp for weight loss should be limited to 12 weeks.
Usual Pediatric Dose for Nasal Congestion
2 to 6 years:
6.25 mg orally every 4 hours. Maximum daily dose is 37.5 mg.
6 to 12 years:
12.5 mg orally every 4 hours. Maximum daily dose is 75 mg.
> 12 years:
25 mg orally every 4 hours.
-or-
75 mg orally extended release every 12 hours.
Not to exceed 150 mg/day.
Renal Dose Adjustments
Because Pediatapp is eliminated primarily by the kidneys, one-half of the normally recommended dosage should be given. Patients with renal dysfunction should be monitored for signs and symptoms of toxicity when using Pediatapp.
Other Comments
In November 2000, the Food and Drug Administration (FDA), in response to reports of increased risk of hemorrhagic stroke, requested that all drug companies discontinue marketing products containing Pediatapp.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
More about Pediatapp
- Pediatapp Side Effects
- During Pregnancy
- Drug Interactions
- Support Group
- 2 Reviews
- Drug class: decongestants
Related treatment guides
- Weight Loss
- Cold Symptoms
- Nasal Congestion
Pediatapp interactions
See also:
What other drugs will affect Pediatapp?
The benzodiazepines, including Ativan (lorazepam), produce increased CNS-depressant effects when administered with other CNS depressants such as alcohol, barbiturates, antipsychotics, sedative/hypnotics, anxiolytics, antidepressants, narcotic analgesics, sedative antihistamines, anticonvulsants, and anesthetics.
Concomitant use of clozapine and lorazepam may produce marked sedation, excessive salivation, hypotension, ataxia, delirium, and respiratory arrest.
Concurrent administration of lorazepam with valproate results in increased plasma concentrations and reduced clearance of lorazepam. Lorazepam dosage should be reduced to approximately 50% when coadministered with valproate.
Concurrent administration of lorazepam with probenecid may result in a more rapid onset or prolonged effect of lorazepam due to increased half-life and decreased total clearance. Lorazepam dosage needs to be reduced by approximately 50% when coadministered with probenecid.
The effects of probenecid and valproate on lorazepam may be due to inhibition of glucuronidation.
Administration of theophylline or aminophylline may reduce the sedative effects of benzodiazepines, including lorazepam.
Pediatapp side effects
See also:
What are the possible side effects of Pediatapp?
Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Just because a side effect is stated here, it does not mean that all people using this medicine will experience that or any side effect.
Constipation.
Skin rash.
Codeine can cause drowsiness, although at the dose contained in this medicine this is very unlikely. However, if you do find this medicine makes you feel sleepy or dizzy you should not drive or operate machinery and avoid alcoholic drink.
The side effects listed above may not include all of the side effects reported by the medicines’s manufacturer. For more information about any other possible risks associated with this medicine, please read the information provided with the medicine or consult your doctor or pharmacist.
Pediatapp contraindications
See also:
What is the most important information I should know about Pediatapp?
Do not use lorazepam if you have narrow-angle glaucoma, or if you are allergic to lorazepam or to other benzodiazepines, such as alprazolam (Xanax), chlordiazepoxide (Librium), clorazepate (Tranxene), diazepam (Valium), or oxazepam (Serax).
Before taking lorazepam, tell your doctor if you are allergic to any drugs, or if you have:
glaucoma;
asthma, emphysema, bronchitis, chronic obstructive pulmonary disorder (COPD), or other breathing problems;
kidney or liver disease;
a history of depression or suicidal thoughts or behavior; or a history of drug or alcohol addiction.
If you have any of these conditions, you may need a dose adjustment or special tests to safely take this medication.
Active ingredient matches for Pediatapp:
Phenylpropanolamine HCl in Philippines.
Brompheniramine maleate in Philippines.
Unit description / dosage (Manufacturer) | Price, USD |
Pediatapp 60 mL | |
Pediatapp 15 mL | |
List of Pediatapp substitutes (brand and generic names): | |
Broramin (Taiwan) | |
Broramin 4 mg x 2 x 6's | |
Broramin 4 mg x 1000's | |
Congestapp (Philippines) | |
Congestapp 60 mL | |
Correctal | |
Correctal 15 ml Drop (Union Drug Company Ltd) | $ 0.03 |
Correctal 60 ml Syrup (Union Drug Company Ltd) | $ 0.03 |
Correctal 4+10 Tablet (Union Drug Company Ltd) | $ 0.02 |
Correctal 100 ml Syrup (Union Drug Company Ltd) | $ 0.03 |
CORRECTAL DROPS 1 packet / 15 ML drop each (Union Drug Company Ltd) | $ 0.51 |
CORRECTAL SYRUP 1 bottle / 60 ML syrup each (Union Drug Company Ltd) | $ 0.49 |
CORRECTAL SYRUP 1 bottle / 100 ML syrup each (Union Drug Company Ltd) | $ 0.58 |
CORRECTAL TABLET 1 strip / 10 tablets each (Union Drug Company Ltd) | $ 0.32 |
Correctal Drop (Union Drug Company Ltd) | $ 0.51 |
Correctal Tablet (Union Drug Company Ltd) | $ 0.03 |
Correctal Plus | |
Correctal Plus 60 ml Syrup (Union Drug Company Ltd) | $ 0.03 |
Correctal Plus Syrup (Union Drug Company Ltd) | $ 0.51 |
Fluzep (Indonesia) | |
Fluzep 10 x 10's (Aan Pharma Pvt Ltd) | $ 8.68 |
Fluzep 2+5 Tablet (Aan Pharma Pvt Ltd) | $ 0.01 |
Harber-Tane | |
Naldec (Philippines) | |
Naldec 12.5 mg/5 mL x 60 mL (IAE) | |
Naldec 6.25 mg/1 mL x 15 mL (IAE) | |
Nasaphen (Philippines) | |
Neo-Coldan (Philippines) | |
Neo-Coldan 6.25 mg/1 mL x 15 mL (Ad-drugstel) | $ 1.40 |
phenylpropanolamine HCl (Indonesia) | |
Probahist (United States) | |
Qrcs | |
Qrcs 100 ml Syrup (Medizone) | $ 0.02 |
Salbrox AP | |
Salbrox AP 100 ml Syrup (Invision Medi Sciences) | $ 0.02 |
Schertane | |
Schertane Tdt | |
Shacold | |
Shacold 500+10+10 Tablet (Sehat Pharma Pvt.Ltd) | $ 0.02 |
Shacold 60 ml Suspension (Sehat Pharma Pvt.Ltd) | $ 0.04 |
Sneezy G Tablet | |
Sneezy G Tablet (Genvista (Cadila Pharmaceuticals Ltd.)) | $ 0.01 |
T Minic | |
T Minic 60 ml Wander Syrup (Wander Ltd) | $ 0.03 |
T Minic 25+4 Wander Tablet (Wander Ltd) | $ 0.03 |
T Minic 15 ml Wander Drop (Wander Ltd) | $ 0.03 |
T Minic 10+4 Tablet (Wander Ltd) | $ 0.03 |
T Minic 15 ml Drop (Wander Ltd) | $ 0.16 |
Tercuf PD | |
Tercuf PD 60 ml Syrup (G Nine Formulations Pvt. Ltd.) | $ 0.03 |
Timon | |
Timon 60 ml Syrup (Times Drugs & Pharmaceuticals (P) Ltd.) | $ 0.02 |
U.R.I. | |
Zedma C | |
Zedma C 60 ml Suspension (Zedchem Pharma) | $ 0.03 |
Zynogen DX | |
Zynogen DX 12.5+10+2 Syrup (Ascent Corporations (Pvt) Ltd) | $ 0.03 |
See 52 substitutes for Pediatapp |
References
- PubChem. "BROMPHENIRAMINE". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "BROMPHENIRAMINE". http://www.drugbank.ca/drugs/DB00835 (accessed September 17, 2018).
- MeSH. "Histamine H1 Antagonists". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Pediatapp are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Pediatapp. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yet3 consumers reported time for results
To what extent do I have to use Pediatapp before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Pediatapp. To get the time effectiveness of using Pediatapp drug by other patients, please click here.
Users | % | ||
---|---|---|---|
1 week | 1 | 33.3% | |
2 days | 1 | 33.3% | |
3 days | 1 | 33.3% |
11 consumers reported age
Users | % | ||
---|---|---|---|
< 1 | 5 | 45.5% | |
6-15 | 3 | 27.3% | |
1-5 | 3 | 27.3% |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology